Search Results - "Vercauteren, Magali"

Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation by Welford, Richard W. D., Vercauteren, Magali, Trébaul, Annette, Cattaneo, Christophe, Eckert, Doriane, Garzotti, Marco, Sieber, Patrick, Segrestaa, Jérôme, Studer, Rolf, Groenen, Peter M. A., Nayler, Oliver

“…The biogenic amine serotonin (5-HT) is a multi-faceted hormone that is synthesized from dietary tryptophan with the rate limiting step being catalyzed by the…”
Get full text

Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B by Gomez, Elodie, Vercauteren, Magali, Kurtz, Baptiste, Ouvrard-Pascaud, Antoine, Mulder, Paul, Henry, Jean-Paul, Besnier, Marie, Waget, Aurélie, Hooft Van Huijsduijnen, Rob, Tremblay, Michel L, Burcelin, Remy, Thuillez, Christian, Richard, Vincent

“…Abstract Protein tyrosine phosphatase 1B (PTP1B) regulates tyrosine kinase receptor-mediated responses, and especially negatively influences insulin…”
Get full text

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension by Iglarz, Marc, Landskroner, Kyle, Bauer, Yasmina, Vercauteren, Magali, Rey, Markus, Renault, Berengère, Studer, Rolf, Vezzali, Enrico, Freti, Diego, Hadana, Hakim, Schläpfer, Manuela, Cattaneo, Christophe, Bortolamiol, Céline, Weber, Edgar, Whitby, Brian R, Delahaye, Stéphane, Wanner, Daniel, Steiner, Pauline, Nayler, Oliver, Hess, Patrick, Clozel, Martine

“…AIMS:We compared the efficacy of macitentan, a novel dual endothelin A/endothelin B receptor antagonist, with that of another dual endothelin receptor…”
Get full text

Heart Rate Reduction Induced by the If Current Inhibitor Ivabradine Improves Diastolic Function and Attenuates Cardiac Tissue Hypoxia by Fang, Yuehua, Debunne, Manuelle, Vercauteren, Magali, Brakenhielm, Ebba, Richard, Vincent, Lallemand, Francoise, Henry, Jean-Paul, Mulder, Paul, Thuillez, Christian

“…AIMSEnhanced heart rate (HR) is a compensatory mechanism in chronic heart failure (CHF), preserving cardiac output, but at the cost of increased left…”
Get full text

Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure by VERCAUTEREN, Magali, REMY, Elise, RICHARD, Vincent, DEVAUX, Corinne, DAUTREAUX, Brigitte, HENRY, Jean-Paul, BAUER, Fabrice, MULDER, Paul, VAN HUIJSDUIJNEN, Rob Hooft, BOMBRUN, Agnès, THUILLEZ, Christian

“…Chronic heart failure (CHF) induces endothelial dysfunction characterized by a decrease in nitric oxide (NO) production in response to flow (flow-mediated…”
Get full text

Assessment of Peripheral Serotonin Synthesis Using Stable Isotope‐Labeled Tryptophan by Gehin, Martine, Welford, Richard W.D., Garzotti, Marco, Vercauteren, Magali, Groenen, Peter M.A., Nayler, Oliver, Sidharta, Patricia N., Dingemanse, Jasper

“…Serotonin (5‐HT) is synthesized from dietary tryptophan (Trp) and plays an important role in numerous diseases of the central nervous system and periphery…”
Get full text

Endothelin ET A Receptor Blockade, by Activating ET B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention by Vercauteren, Magali, Trensz, Frederic, Pasquali, Anne, Cattaneo, Christophe, Strasser, Daniel S, Hess, Patrick, Iglarz, Marc, Clozel, Martine

“…Endothelin (ET) receptor antagonists have been associated with fluid retention. It has been suggested that, of the two endothelin receptor subtypes, ET…”
Get more information

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone by Mulder, Paul, Mellin, Virginie, Favre, Julie, Vercauteren, Magali, Remy-Jouet, Isabelle, Monteil, Christelle, Richard, Vincent, Renet, Sylvanie, Henry, Jean Paul, Jeng, Arco Y., Webb, Randy L., Thuillez, Christian

“…Aims Inhibition of aldosterone synthase, the key enzyme in aldosterone formation, could be an alternative strategy for mineralocorticoid-receptor antagonists…”
Get full text

Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B by Gomez, Elodie, Vercauteren, Magali, Kurtz, Baptiste, Ouvrard-Pascaud, Antoine, Mulder, Paul, Henry, Jean-Paul, Besnier, Marie, Waget, Aurélie, Huijsduijnen, Rob Hooft Van, Tremblay, Michel L., Burcelin, Rémy, Thuillez, Christian, Richard, Vincent

“…Protein tyrosine phosphatase 1B (PTP1B) regulates tyrosine kinase receptor-mediated responses, and especially negatively influences insulin sensitivity, thus…”
Get full text

Abstract 3552: Pharmacological Inhibition or Genetic Disruption of Protein Tyrosine Phosphatase 1B Attenuates both Myocardial and Endothelial Dysfunction in Mice with Heart Failure by Vercauteren, Magali, Kurtz, Baptiste, Gomez, Elodie, Henry, Jean-Paul, Bauer, Fabrice, Hooft, Rob, Tremblay, Michel L, Thuillez, Christian, Richard, Vincent

“…Abstract only We have shown previously that acute, in vitro inhibition of protein tyrosine phosphatase 1B (PTP1B) improved endothelial function of peripheral…”
Get full text

New pharmacological approaches in heart failure: should we treat the endothelium? by Richard, Vincent, Vercauteren, Magali, Gomez, Elodie, Thuillez, Christian

“…Heart failure is associated with endothelial dysfunction, characterized especially by a decreased nitric oxide (NO) production. The main consequences of this…”
Get more information

Response to Letter Regarding Article, “Improvement of Peripheral Endothelial Dysfunction by Protein Tyrosine Phosphatase Inhibitors in Heart Failure” by Vercauteren, Magali, Remy, Elise, Devaux, Corinne, Dautreaux, Brigitte, Henry, Jean-Paul, Bauer, Fabrice, Mulder, Paul, Thuillez, Christian, Richard, Vincent, Hooft van Huijsduijnen, Rob, Bombrun, Agnès

Get full text